ORIC Annual EBITDA
-$109.75 M
-$23.95 M-27.91%
31 December 2023
Summary:
As of January 20, 2025, ORIC annual earnings before interest, taxes, depreciation & amortization is -$109.75 million, with the most recent change of -$23.95 million (-27.91%) on December 31, 2023. During the last 3 years, it has fallen by -$61.38 million (-126.88%). ORIC annual EBITDA is now -411.22% below its all-time high of -$21.47 million, reached on December 31, 2018.ORIC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORIC Quarterly EBITDA
-$38.05 M
-$2.30 M-6.44%
30 September 2024
Summary:
As of January 20, 2025, ORIC quarterly earnings before interest, taxes, depreciation & amortization is -$38.05 million, with the most recent change of -$2.30 million (-6.44%) on September 30, 2024. Over the past year, it has dropped by -$9.62 million (-33.85%). ORIC quarterly EBITDA is now -523.33% below its all-time high of -$6.10 million, reached on March 1, 2019.ORIC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORIC TTM EBITDA
-$133.69 M
-$9.62 M-7.76%
30 September 2024
Summary:
As of January 20, 2025, ORIC TTM earnings before interest, taxes, depreciation & amortization is -$133.69 million, with the most recent change of -$9.62 million (-7.76%) on September 30, 2024. Over the past year, it has dropped by -$33.23 million (-33.08%). ORIC TTM EBITDA is now -2090.15% below its all-time high of -$6.10 million, reached on March 1, 2019.ORIC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORIC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.9% | -33.9% | -33.1% |
| 3 y3 years | -126.9% | -33.9% | -33.1% |
| 5 y5 years | -411.2% | -33.9% | -33.1% |
ORIC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.8% | at low | -86.1% | at low | -71.5% | at low |
| 5 y | 5-year | -298.5% | at low | -347.6% | at low | -385.4% | at low |
| alltime | all time | -411.2% | at low | -523.3% | at low | -2090.2% | at low |
ORIC Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$38.05 M(+6.4%) | -$133.69 M(+7.8%) |
| June 2024 | - | -$35.74 M(+24.4%) | -$124.06 M(+9.7%) |
| Mar 2024 | - | -$28.73 M(-7.8%) | -$113.05 M(+3.0%) |
| Dec 2023 | -$109.75 M(+27.9%) | -$31.16 M(+9.6%) | -$109.75 M(+9.3%) |
| Sept 2023 | - | -$28.43 M(+14.9%) | -$100.45 M(+8.6%) |
| June 2023 | - | -$24.73 M(-2.7%) | -$92.50 M(+4.9%) |
| Mar 2023 | - | -$25.43 M(+16.2%) | -$88.22 M(+2.8%) |
| Dec 2022 | -$85.80 M(+10.0%) | -$21.87 M(+6.8%) | -$85.80 M(-0.8%) |
| Sept 2022 | - | -$20.47 M(+0.1%) | -$86.50 M(+2.7%) |
| June 2022 | - | -$20.45 M(-11.1%) | -$84.27 M(-0.5%) |
| Mar 2022 | - | -$23.01 M(+1.9%) | -$84.66 M(+8.6%) |
| Dec 2021 | -$77.97 M | -$22.58 M(+23.8%) | -$77.97 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$18.24 M(-12.5%) | -$71.57 M(+8.9%) |
| June 2021 | - | -$20.84 M(+27.6%) | -$65.73 M(+17.9%) |
| Mar 2021 | - | -$16.32 M(+0.9%) | -$55.77 M(+15.3%) |
| Dec 2020 | -$48.37 M(+75.6%) | -$16.18 M(+30.5%) | -$48.37 M(+18.9%) |
| Sept 2020 | - | -$12.39 M(+13.9%) | -$40.70 M(+15.8%) |
| June 2020 | - | -$10.88 M(+21.8%) | -$35.13 M(+15.7%) |
| Mar 2020 | - | -$8.93 M(+5.0%) | -$30.37 M(+10.3%) |
| Dec 2019 | -$27.54 M(+28.3%) | -$8.50 M(+24.5%) | -$27.54 M(+44.6%) |
| Sept 2019 | - | -$6.83 M(+11.8%) | -$19.04 M(+55.9%) |
| June 2019 | - | -$6.11 M(+0.1%) | -$12.21 M(+100.1%) |
| Mar 2019 | - | -$6.10 M | -$6.10 M |
| Dec 2018 | -$21.47 M | - | - |
FAQ
- What is ORIC Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual EBITDA year-on-year change?
- What is ORIC Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly EBITDA year-on-year change?
- What is ORIC Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals TTM EBITDA year-on-year change?
What is ORIC Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ORIC is -$109.75 M
What is the all time high annual EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$21.47 M
What is ORIC Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ORIC annual earnings before interest, taxes, depreciation & amortization has changed by -$23.95 M (-27.91%)
What is ORIC Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ORIC is -$38.05 M
What is the all time high quarterly EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.10 M
What is ORIC Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ORIC quarterly earnings before interest, taxes, depreciation & amortization has changed by -$9.62 M (-33.85%)
What is ORIC Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ORIC is -$133.69 M
What is the all time high TTM EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.10 M
What is ORIC Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ORIC TTM earnings before interest, taxes, depreciation & amortization has changed by -$33.23 M (-33.08%)